FORTRESS BIOTECH INC - COM (FBIO)

CUSIP: 34960Q109

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / COM
Total 13F shares
24,149,052
Share change
-4,736,563
Total reported value
$13,278,866
Put/Call ratio
6.3%
Price per share
$0.55
Number of holders
46
Value change
-$3,435,262
Number of buys
14
Number of sells
24

Quarterly Holders Quick Answers

What is CUSIP 34960Q109?
CUSIP 34960Q109 identifies FBIO - FORTRESS BIOTECH INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FORTRESS BIOTECH INC - COM (FBIO) as of Q2 2023

As of 30 Jun 2023, FORTRESS BIOTECH INC - COM (FBIO) was held by 46 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,149,052 shares. The largest 10 holders included Nantahala Capital Management, LLC, VANGUARD GROUP INC, Opaleye Management Inc., PERKINS CAPITAL MANAGEMENT INC, BlackRock Inc., SHIKIAR ASSET MANAGEMENT INC, ACADIAN ASSET MANAGEMENT LLC, Corient Private Wealth LLC, GEODE CAPITAL MANAGEMENT, LLC, and 1900 WEALTH MANAGEMENT LLC. This page lists 46 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.